Literature DB >> 6076613

An hypothesis on the mechanism of action of 6-thioguanine.

R P Miech, R E Parks, J H Anderson, A C Sartorelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6076613     DOI： 10.1016/0006-2952(67)90022-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  7 in total

1.  Phase II trial of 5 day continuous intravenous infusion of 6-thioguanine in patients with recurrent and metastatic squamous cell carcinoma of the head and neck.

Authors:  F Kruter; M Eisenberger; V Sinibaldi; C Engstrom; M Jacobs; J Abrams; C Belani; W Gray; S Krasnow
Journal:  Invest New Drugs       Date:  1992-07       Impact factor: 3.850

2.  Differences between rat liver epithelial cells and fibroblast cells in sensitivity to 8-azaguanine.

Authors:  J J Berman; C Tong; G M Williams
Journal:  In Vitro       Date:  1980-08

3.  Purines as 'hyper-repressors' of glucose transport. A role for phosphoribosyl diphosphate.

Authors:  R J Gay; H Amos
Journal:  Biochem J       Date:  1983-07-15       Impact factor: 3.857

4.  An enumerative assay of purine analogue resistant lymphocytes in women heterozygous for the Lesch-Nyhan Mutation.

Authors:  G H Strauss; E F Allen; R J Albertini
Journal:  Biochem Genet       Date:  1980-06       Impact factor: 1.890

5.  Toxicity of 6-thioguanine and 8-azaguanine to non-dividing liver cell cultures.

Authors:  J J Berman; C Tong; G M Williams
Journal:  Cell Biol Toxicol       Date:  1985-01       Impact factor: 6.691

Review 6.  The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach.

Authors:  A C Sartorelli
Journal:  Br J Cancer       Date:  1985-09       Impact factor: 7.640

7.  6-thioguanine: antimitotic effect on human lymphocytes in vitro prevented by adenine.

Authors:  D J Price; J Timson
Journal:  Br J Cancer       Date:  1971-03       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.